How will CYDY attack 2011 highs with COVID treatment results?

Here's another possible fractal path for CYDY over coming weeks. It appears to be consolidating and basing in 2.76-3.2 zone ready for an attack on 3.57-3.65, then 3.83-4 and eventually the old 2011 all-time high around 4.4 (when there were WAY fewer outstanding shares!). This sort of stair-stepped march-up can be expected so long as trial results and partnering news continue to trickle out a few patients at a time over the next few weeks. However, keep in mind that a sudden FDA emergency approval or tweets by Trump about leronlimab could spike CYDY into 5-10 range instantaneously, bypassing these lazy zig-zags.